1. DIFFERENCE IN THE INTENSITY OF DEPRESSION IN PATIENTS TREATED WITH METHADONE REPLACEMENT THERAPY COMPARED TO PATIENTS TREATED WITH BUPRENORPHINE REPLACEMENT THERAPY
- Author
-
Papić, Nikola, Lasić, Davor, Glavina, Trpimir, Uglešić, Boran, and Pecotić, Renata
- Subjects
methadone ,Heroinski ovisnici ,BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Psihijatrija ,buprenorfin ,metadon ,depression ,BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Psychiatry ,depresija ,Heroin addicts ,buprenorphine - Abstract
Ciljevi istraživanja: Glavni ciljevi ovoga istraživanja bili su usporediti intenzitet depresije, kao i rezultat na pojedinačne tvrdnje Beck Depression Inventory-II (BDI-II) upitnika među pacijentima liječenim supstitucijskom terapijom metadonom i onima liječenim supstitucijskom terapijom buprenorfinom. Materijali i metode: U Službi za mentalno zdravlje na Nastavnom zavodu za javno zdravstvo Splitsko-dalmatinske županije u razdoblju od 18. ožujka 2021. do 29. travnja 2021. godine. ispitanici liječeni supstitucijskom terapijom buprenorfinom ili metadonom ispunili su Beck Depression Inventory-II ( BDI-II) upitnik. Također, iz Pompidou obrazaca prikupljeni su podaci o pacijentovim općim socio-demografskim podacima, podacima o liječenju, rizičnom ponašanju i sudskim problemima. Rezultati: U navedenom razdoblju istraživanje je obuhvatilo 103 ispitanika, od kojih je njih 84 (81,6%) bilo muškog spola te 19 (18,4%) ženskog spola. 47 ispitanika (45,6%) liječeni su supstitucijskom terapijom buprenorfinom, dok je ostalih 56 (54,4%) bilo liječeno supstitucijskom terapijom metadonom. Zbrajanjem rezultata koje su postigli rješavajući Beck Depression Inventory-II ( BDI-II) upitnik, 50 ispitanika (48,6%) imalo je minimalnu depresiju, njih 21 (20,4%) blagu, 16 (15,5)% umjerenu, a isti broj, njih 16, imao je težak oblik depresije, bez statistički značajnih razlika među istraživanim grupama. Pokazana je statistički značajna (P, Diploma thesis title: Difference in the intensity of depression in patients treated with methadone replacement therapy compared to patients treated with buprenorphine replacement therapy. Objectives: The main objectives of this study were to compare the intensity of depression and scores on individual claims of the Beck Depression Inventory-II (BDI-II) questionnaire among patients treated with methadone replacement therapy and those treated with buprenorphine replacement therapy. Materials and methods: In the Mental Health Services at the Teaching Institute for Public Health of the Split-Dalmatia County in the period from March 18, 2021. to April 29, 2021. subjects treated with buprenorphine or methadone replacement therapy completed the Beck Depression Inventory-II (BDI-II) questionnaire. Also, data on patient general socio-demographic data, treatment data, risky behavior, and court problems were collected from Pompidou forms. Results: In this period, the study included 103 respondents, of whom 84 (81.6%) were male and 19 (18.4%) female. 47 subjects (45.6%) were treated with buprenorphine replacement therapy, while the remaining 56 (54.4%) were treated with methadone replacement therapy. Summarizing the results achieved by solving the Beck Depression Inventory-II (BDI-II) questionnaire, 50 respondents (48.5%) had minimal depression, 21 of them (20.4%) had mild depression, 16 (15.5%) had moderate depression, and the same number, 16 of them, had a severe form of depression., with no statistically significant differences among the study groups. There was a statistically significant (P
- Published
- 2021